When Amy Smilovic created the fashion line Tibi in 1997, she was living in Hong Kong. Navigating foreign trade rules added additional challenges to the already difficult task of starting a new business.
Smilovic joins to discuss how she was able to get the company off the ground before eventually relocating back the United States. She highlights that, beyond foreign trade rules, you also have to take language barriers into consideration.
In the 20 years since Tibi was founded, the retail industry has gone through massive changes. The rise of e-commerce has forced clothing brands to alter their sales strategies. Smilovic explains how Tibi made the adjustment to online, and predicts how much growth she expects to see in e-commerce.
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
